Tap to enable a layout that focuses on the article.
Advertisement
Business

Syncor Corp. to Buy Iodine 123 Business

L.A. Times Archives

Syncor International Corp., a Chatsworth operator of nuclear pharmacies, said that it has signed a letter of intent with Golden Pharmaceuticals Inc. to buy the company’s Iodine 123 business.

Iodine 123 is used to diagnose thyroid problems.

Previously, Golden was supplying Iodine 123 to Syncor’s network of 130 nuclear pharmacy service centers.

More to Read

Business

Inside the business of entertainment

The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.

By continuing, you agree to our Terms of Service, which include arbitration and a class action waiver. You agree that we and our third-party vendors may collect and use your information, including through cookies, pixels and similar technologies, for the purposes set forth in our Privacy Policy such as personalizing your experience and ads.

More From the Los Angeles Times

Most Read in Business

Advertisement
Advertisement